Capital Performance Advisors LLP Wave Life Sciences Ltd. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 13 shares of WVE stock, worth $200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$280 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$155 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$150 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$104 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$95 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.34B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...